NEWS

Sunlight Pharmaceutical and Spain Uria joint venture project laid the foundation

Release time:2023-04-18
Views:414
[Abstract] : Accelerate the transformation and upgrading of industrial structure and promote sustainable and stable economic development. On November 8, Changzhou Sunlight Pharmaceutical Co., Ltd. and Spain Uria Pharmaceutical Group joint venture project held a foundation stone ceremony in Benniu Town. Wujin district leaders Zhang Mei, Zhou Yaonan attended.

We will accelerate the transformation and upgrading of the industrial structure and promote sustained and steady economic development. On November 8, Changzhou Sunlight Pharmaceutical Co., Ltd. and Spain Uria Pharmaceutical Group joint venture project held a foundation stone ceremony in Benniu Town. Wujin district leaders Zhang Mei, Zhou Yaonan attended.


mNyR8UN6RMmSGeOolJ2pbQ.jpg


After more than 20 years of development, Changzhou Sunlight  Pharmaceutical has accumulated rich experience in the pharmaceutical industry, and established long-term cooperative relations with a number of global top 500 enterprises, such as Pfizer, DuPont, BASF, Novartis, GlaxoSmithKline, Sanofi, Aventis, Rhodia, Sweden, JSR, Japan. Japan's Mitsubishi, South Korea's Samsung and other groups; And trade with 39 countries around the world. "Uria Pharma Group" is one of the three major pharmaceutical groups in Spain with a long history of more than 170 years. The joint venture project for Changzhou Sunlight  Pharmaceutical Co., Ltd. and Spain Uria Pharmaceutical Group to establish a new, the introduction of the world's most advanced pharmaceutical technology and technology, production and sales of the current domestic blank series of new drugs, the total investment of the project 450 million yuan, the first phase will build API workshop, pharmaceutical workshop, finished product warehouse, quality inspection center, R & D technology center, etc. To form a comprehensive new drug production and development base integrating API, production, research and development of various preparations, and technical services. The second phase will build high-end varieties and new dosage forms such as anti-tumor drugs and freeze-dried powder injections. After the project is completed and put into operation, the output value can reach 2 billion yuan, and the annual profit and tax will be 560 million yuan.

In recent years, Benniu Town has continuously increased innovation investment, accelerated the transformation and upgrading of industrial structure, sustained and stable economic development, and comprehensive progress of social undertakings. The formal foundation of the joint venture project will make new and greater contributions to the economic development of Benniu.